Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?
Publication
, Journal Article
Gurbel, PA; Tantry, US
Published in: JACC Cardiovasc Interv
October 2010
Duke Scholars
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 2010
Volume
3
Issue
10
Start / End Page
1008 / 1010
Location
United States
Related Subject Headings
- Ticlopidine
- Risk Factors
- Risk Assessment
- Receptors, Purinergic P2Y12
- Predictive Value of Tests
- Polymorphism, Genetic
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Phenotype
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2010). Acceptance of high platelet reactivity as a risk factor: now, what do we do about it? JACC Cardiovasc Interv, 3(10), 1008–1010. https://doi.org/10.1016/j.jcin.2010.08.011
Gurbel, Paul A., and Udaya S. Tantry. “Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?” JACC Cardiovasc Interv 3, no. 10 (October 2010): 1008–10. https://doi.org/10.1016/j.jcin.2010.08.011.
Gurbel PA, Tantry US. Acceptance of high platelet reactivity as a risk factor: now, what do we do about it? JACC Cardiovasc Interv. 2010 Oct;3(10):1008–10.
Gurbel, Paul A., and Udaya S. Tantry. “Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?” JACC Cardiovasc Interv, vol. 3, no. 10, Oct. 2010, pp. 1008–10. Pubmed, doi:10.1016/j.jcin.2010.08.011.
Gurbel PA, Tantry US. Acceptance of high platelet reactivity as a risk factor: now, what do we do about it? JACC Cardiovasc Interv. 2010 Oct;3(10):1008–1010.
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 2010
Volume
3
Issue
10
Start / End Page
1008 / 1010
Location
United States
Related Subject Headings
- Ticlopidine
- Risk Factors
- Risk Assessment
- Receptors, Purinergic P2Y12
- Predictive Value of Tests
- Polymorphism, Genetic
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Phenotype